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Abstract. The complete primary structure of an inte- 
gral membrane glycoprotein of the nuclear pore was 
deduced from the eDNA sequence. The cDNA en- 
codes a polypeptide of 204,205  D  containing a 25- 
residue-long signal sequence, two hydrophobic 
segments that could function as transmembrane 
segments, and 13 potential N-linked oligosaccharide 
addition sites.  Endoglycosidase H reduces the molecu- 
lar mass by '~9 kD suggesting that not all of these 13 
sites are used. We discuss possible models for the to- 
pology of this protein in the pore membrane as well as 
a possible role in the formation of pores and pore 
complexes. 
T  H  F. outer and inner membranes of  the nuclear envelope 
are continuous with each other at distinct circular sites 
of "~90 nm in diameter,  termed  nuclear pores  (15). 
The nuclear pore is occupied by the nuclear pore complex, 
a supramolecular ensemble of  an estimated mass of--50-100 
x  106 D (for reviews see 14, 28). Transport of proteins and 
nucleic acids in and out of the nucleus proceeds via the nu- 
clear pore complex (7,  11). 
An integral  membrane  protein  of an estimated  190  kD 
containing asparagine-linked,  high mannose-type oligosac- 
charides  (gpl90)  has recently been shown by immunoelec- 
tron microscopy to be associated with the nuclear pore com- 
plex (19). The finding that gpl90 remains associated with 
nuclear  pore complexes after solubilization of the nuclear 
envelope lipids with nonionic detergent suggests that gpl90 
spans the pore membrane and possesses a domain exposed 
to the nuclear  pore complex and a domain containing the 
asparagine-linked  oligosaccharides  exposed to the perinu- 
clear cisternae.  Association with the nuclear pore complex 
suggests that gpl90 may function in anchoring pore complex 
components to the pore membrane  (19). 
Recently, Unwin and Milligan have examined the nuclear 
pore complex using Fourier averaging methods on negatively 
stained  images  (39). They observed  two "ring"  structures 
composed of eight globular subunits lying parallel to the nu- 
clear envelope, one on the cytoplasmic face and the other on 
the nucleoplasmic  face  of the nuclear  envelope. Between 
these two rings, a set of eight "spokes" radiate in from the 
vicinity of  the outer and inner membrane junction toward the 
center of the pore. These spokes surround a central "plug" 
located in the center of  the pore complex. The pore complex 
is thus positioned around two axes of symmetry. A central 
axis showing octahedral symmetry passes through the cen- 
tral plug perpendicular  to the surface of the nuclear enve- 
lope. The other axis is perpendicular  to the central axis and 
essentially divides the pore complex into oppositely facing 
halves. If gpl90 was involved in anchoring one each of the 
eight subunits of the inner and outer ring (or spokes) of the 
pore complex, one would expect 16 copies of  gpl90 per pore 
complex in good agreement with the estimated number of 
16-24 gpl90 (18). 
As a step toward an understanding of  the function of  gpl90, 
we deduced the complete primary structure of gpl90 from 
the eDNA sequence. The primary structure reveals a poly- 
peptide of •  204,205 D containing a cleaved signal sequence 
and two predicted transmembrane segments. On the basis of 
the primary structure  and the mass of endoglycosidase H 
(Endo H)'-sensitive  oligosaccharides on gpl90, the total es- 
timated mass would be --210 kD. Therefore, we will refer to 
this protein as gp210. We discuss possible models for the to- 
pology of gp210 in the pore membrane as well as a possible 
role of gp210 in formation and elimination of pores and pore 
complexes. 
Materials and Methods 
Rat Liver Nuclei Isolation 
Rat liver nuclei were isolated from 150-200-g Sprague Dawley rats after 
20-24 h of starvation as described by Blobel and Potter (3). The following 
modifications were incorporated into the isolation procedure. All solutions 
were buffered with 20 mM triethanolamine (TEA)-HCI, pH 7.5, and con- 
tained 0.5 mM PMSE The homogenization buffer was supplemented with 
2.5 mM iodoacetamide. After homogenization and before ultracentrifuga- 
tion the homogenate was made 5 mM in DTT.  All subsequent buffers con- 
tained 1 mM DTT. 
Fractionation of Nuclei 
Nuclear envelopes were isolated as described by Dwyer and Blobel (8) with 
the following modifications. All solutions contained 0.5 mM PMSF and 1 
1. Abbreviations  used in this paper:  Endo H, endoglycosidase H; TEA, 
triethanolamine. 
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RNase was added to both nuclease digestion steps. 
Isolated nuclear envelopes were then fractionated to yield a pore com- 
plex-lamina fraction (8) or extracted consecutively with urea and Nikkol 
(Nikkol Chemical, Tokyo, Japan) as follows. Nuclear envelopes were in- 
cubated in 4 M urea,  10% (wt/vol) sucrose, 10 mM TEA-HC1, pH 7.5, 5 
mM MgCI2 for 5 min on ice at --4 mg total protein/ml extraction buffer. 
The suspension was centrifuged for 15 min at 16,000 gay. The supernatant 
was removed and the resulting pellet resuspended at *1 mg protein/ml in 
50 mM TEA-HC1, pH 7.5, 5 mM MgC12, 0.5 mM PMSF, and 1 mM DTT. 
An equal volume of 50 mM TEA-HCI, pH 7.5, 2% Nikkol, 100 mM NaCI, 
5 mM MgCI2, 0.5 mM PMSF, and 1 mM DTT was then added. After in- 
cubating the sample for 10 min on ice, it was underlaid with 30% (wt/vol) 
sucrose,  50  mM TEA-HCI,  pH  7.5,  1%  Nikkol,  50  mM NaC1,  5  mM 
MgClz, 0.5 mM PMSF,  1 mM DTT,  and centrifuged at 16,000 gay for 20 
min at 4°C. 
Isolation of  gp210 
The pore complex-lamina fraction or the urea/Nikkol-extracted nuclear 
envelopes were used as starting material for the isolation of gp210. Purifica- 
tion was performed using a strategy similar to that previously reported for 
the Drosophila melanogaster homolog of the rat gp210 (12).  Either of the 
above fractions were solubilized by heating at 56°C for 20 min in 2% SDS, 
25 mM Tris-HCl, pH 7.5, 200 mM NaC1,  1 mM EDTA, 0.5 mM PMSE 
and 10 mM DTT at a concentration of 3-5 mg protein/ml. After cooling 
to room temperature, the sample was loaded onto a Sephacryl S-400 gel ill- 
tration column (Pharmacia Fine Chemicals, Piseataway,  NJ), equilibrated, 
and eluted with 0.5% SDS, 20 mM NaPi, pH 6.8, 200 mM NaCI, 0.5 mM 
EDTA, and 1 mM DTT at room temperature. Fractions were analyzed by 
SDS-PAGE, and those containing gp210 were pooled. Pooled fractions were 
dialyzed at room temperature against 0.4% SDS, 25 mM TEA-HCI, pH 7.5, 
200 mM NaCI, and 1 mM DTT. Dialyzed fractions were supplemented with 
Triton X-100 (2% final concentration), MgCI2 (1 mM final concentration), 
and MnCI2  (1  mM final  concentration) and chilled on ice. This material 
was loaded onto a preequilibrated lentil lectin-Sepharose column (Pharma- 
cia Fine Chemicals) at a concentration of ",~0.3-0.5 mg protein/ml, using 
"~l  mg protein/ml of lectin-Sepharose. Loading was performed overnight 
at 4°C by continuously recycling the sample through the column at a flow 
rate of --4 ml/h.  The column was then washed at 4°C with 25  column 
volumes of 2% Triton X-100, 0.4%  SDS, 25 mM TEA-HCI, pH 7.5, 200 
mM NaC1,  1 mM DTT, and 0.1 mM PMSE Elution was performed at room 
temperature using three column volumes of wash buffer supplemented with 
1 M  a-methylmannoside. Eluted fractions were analyzed by SDS-PAGE. 
Fragmentation of  gp210 by CNBr or 
Staphylococcus  aureus I78 Protease 
Fractions eluted from lentil lectin-Sepharose (above) were used for protein 
sequence analysis.  Peak fractions containing gp210 were pooled and precipi- 
tated with 10% (wt/vol) TCA. Pellets were washed once with 5% TCA and 
2 mM DTT and then twice with 90 % ethanol. The final pellets were used for 
CNBr or S.  aureus V8 protease fragmentation. For CNBr digest, 100 p.g 
of protein was dissolved in 1.8 ml of 0.85 M CNBr in 70% (vol/vol) formic 
acid and incubated at room temperature for 24 h (20). After incubation, 1 
ml of water was added and the sample was lyophilized to dryness. The 
resulting fragments were separated on a 15 % urea-SDS-polyacrylamide gel 
(29) and electroeluted as described (23).  V8 protease (Boehringer Mann- 
heim Biochemicals, Indianapolis, IN) digestions were performed as fol- 
lows.  100/~g of protein was solubilized in 0.4% SDS, 250 mM Tris-HCI, 
pH 6.8, and 40 mM DTT.  V8 protease was added to final concentration of 
0.125 mg/ml, and the sample was incubated at room temperature for 1.5 h. 
Fragments were precipitated with 10% TCA, and the resulting pellet was 
washed three times with 90%  ethanol. Peptides were then solubilized in 
8 M  urea and  resolved by  reverse-phase HPLC  (Beckman Instruments, 
Inc., San Ramon, CA). Separation was achieved by sequentially resolving 
peptides on a C4 and then on a C8 column tz.1  x  30 nun; Brownlee Aqua- 
pore; Applied Biosystems, Inc., Foster City, CA).  Peptides were eluted 
using a 2-h linear gradient of 0-50% acetonitrile in 0.1% trifluoroacetic  acid. 
Protein Sequencing 
Selected peptides from CNBr and V8 protease cleavage, as well as intact 
gp210, were subjected to sequence analysis on a gas-phase protein sequena- 
tor (Applied Biosystems, Inc.). 
RNA Methods 
The rat hepatoma cell line N1SI (American Type Culture Collection, Rock- 
ville, MD) was chosen as the source for RNA. These cells can be grown 
as suspension cultures with a doubling time of •16  h. The cells were grown 
in DME (Gibco Laboratories, Grand Island, NY) supplemented with 10% 
FCS 0.1  mM MEM-nonessential amino acids (Gibeo Laboratories), and 
5 mM glutamine. RNA was purified from l-liter cultures in mid log phase. 
Cells were pelleted and rapidly solubilized in 4 M guanidinium thiocyanate, 
0.5%  sodium laurylsarcosine, 25 mM EDTA, pH 7.5, 0.13%  antifoam A 
(Sigma Chemical Co., St. Louis, MO) as described by Freeman et al. (16). 
The resulting solution was homogenized in a tight-fitting Potter-Elvehjem 
homogenizer to shear the genomic DNA. The solution was then layered onto 
a CsCI gradient consisting of 3 ml of 5.7 M CsCI, 25 mM sodium acetate, 
pH 5.5,  10 mM EDTA (bottom) and 0.7 ml of 2.4 M CsCI, 25 mM sodium 
acetate, pH 5.5,  10 mM EDTA (top), and spun for 24 h at 20°C in a rotor 
(SW41; Beckman Instruments, Inc.) at  114,000 gay. The RNA pellet was 
poly A + selected by two cycles of oligo-dT cellulose (Boehringer Mann- 
helm Biochemicals) chromatography. For Northern blot analysis, poly A + 
RNA was separated on 1% agarose, 2.2 M formaldehyde gels and blotted 
to nitrocellulose (37).  Blots were probed with 32P-labeled oligonucleotides 
under conditions identical to those described for the screening of eDNA 
libraries (see below). RNA used in eDNA synthesis was prepared as fol- 
lows. 100/~g of poly A + RNA in 10 mM Tris-HCl, pH 7.5, 5 mM EDTA 
was layered onto a 5-25% sucrose gradient in 10 mM Tris-HCl, pH 7.5, 
5 mM EDTA and spun for 12 h at 140,000 gay in a rotor (SW41; Beckman 
Instruments, Inc.). For RNA size determination, sucrose gradient fractions 
were run on 1% agarose, 2.2 M formaldehyde gels and compared to a ladder 
of RNA markers (Bethesda Research Laboratories, Gaithersburg, MD). 
Construction and Screening of Libraries 
Both plasmid and h  Zap libraries were constructed from 10/zg of size- 
fractionated poly A* RNA (4-10 kb range) from rat N1SI cells. For the 
plasmid library,  eDNA was synthesized with random primers using the 
modified Gubler and Hoffman (22) procedure.  After addition of Bst XI 
linkers (Invitrogen, San Diego, CA), the eDNA was size fractionated on a 
1% alkaline agarose gel. eDNA in the size range of 1.5-10 kbp was electro- 
eluted and ligated into the vector pTZISR-B (Invitrogen). Transfection of 
DH5,-competent cells (Bethesda Research Laboratories) yielded 250,000 
colonies. The X Zap library was custom made by Stratagene (La Jolla, CA) 
using random and oligo-dT-primed first-strand synthesis. 
Synthesis of a gp210-specific cDNA Probe 
A specific double-stranded eDNA probe was synthesized based on a 40- 
amino acid sequence (termed p43-F4) of  overlapping CNBr and V8 protease 
fragments (see Fig.  1 b) using modifications of a procedure described by 
Lee et al. (26).  The procedure uses the polymerase chain reaction (31) in 
a mixed oligonucleotide primed amplification of eDNA. Briefly,  two par- 
tially degenerate oligonucleotide primers were synthesized based on the 
sense sequence of amino acids  1-6 (sense primer) and the antisense se- 
quence of  amino acids 31-36 (antisense primer) of p43-F4. Eight-nucleotide 
Eco RI and Hind III restriction enzyme linkers were added to the 5' end of 
the sense and antisense primers, respectively (see Fig. 2).  Primers were 
purified on 15% acrylamide gels (32).  Using random primers, first-strand 
eDNA was synthesized from size-selected poly A* RNA derived from the 
rat hepatoma cell line NISI. The in vitro amplification was catalyzed with 
Taq polymerase (34) under the following conditions. Aproximately 0.1 #g 
of randomly primed, first-strand eDNA and 5 ~tg of both the sense and an- 
tisense primer mixtures were solubilized in 0.1 ml of 50 mM KCI, 10 mM 
Tris-HCI, pH 8.3,  1.5 mM MgC12, 0.01% gelatin, 0.2 mM each of dATE 
dCTP,  dGTP,  and dTTP,  and 250  U  of Taq  polymerase (Perkin-Elmer 
Corp., Norwalk, CT). The sample was then overlaid with 0.1 ml of mineral 
oil and exposed to 25 cycles of denaturation (95°C for 1.5 min), annealing 
(45°C for 2.5 min), and polymerization (72°C for 3 min). The final poly- 
merization step was performed for 7 min at 72°C. Reaction products were 
analyzed on a 7% acrylamide gel. The major h'agment of 123 bp was iso- 
lated from a  low-melting agarose gel (NuSieve GTG; FMC BioProducts, 
Rockland,  ME).  The isolated fragment was then subcioned into pUCI9 
(New England Biolabs, Beverly, MA) and sequenced. 
Two additional amplification products of 567 (N43-amp) and of 543 bp 
(COOH-amp) were produced to confirm eDNA sequence information in 
specific regions of the gp210 reading frame (see Fig. 4). The amplification 
reaction was performed as described above with the following exceptions. 
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polymerization step  extended to  10  min.  Subsequent analysis was  per- 
formed as described above.  N43-amp was  synthesized  using a  partially 
degenerate sense primer based on the first five amino acids of the amino 
terminus and a unique antisense primer based on the sequence IM3-F4 am- 
plification product. COOH-amp was synthesized using unique sense and an- 
tisense primers generated from the sequence of a cDNA clone. 
Screening of cDNA Libraries 
Initial stages of cDNA isolation (see Fig. 4) were performed using a 77-mer 
oligonucleotide  complementary to the sense strand of the IM3-F4 amplifica- 
tion product (termed 45). Oligonucleotide  45 was used to probed 250,000 
reeombinants of the pTZ18R-B plasmid library described above.  Replica 
lifts ~re  performed essentially as described (21). Filters  were prehybrid- 
ized at 65°C for 1-3 h in a solution containing 50% formamide,  5×  Den- 
hardt's solution, 0.2% SDS, 50 mM NaPi,  pH 7.7, 900 mM NaCI,  5 mM 
EDTA, and 100 #g/ml denatured salmon sperm DNA. Oligonucleotide  45 
was  labeled with X-[32p]ATP (Dupont Co.,  Boston, MA) using polynu- 
cleotide kinase (New  England Biolabs). Hybridization was performed at 
42°C for 24 h using ",3  ×  105 cpm labeled oligonucleotide/ml  hybridiza- 
tion buffer (prehybridization buffer with 250 #g/ml tRNA replacing salmon 
sperm DNA).  Filters  were washed  three times at room temperature,  and 
then twice at 60"C in a solution of I x  SSC and 0.1% SDS. Positive colonies 
were purified and plasmid DNA was analyzed by restriction enzyme diges- 
tion and sequencing. 
Using the sequence of one partial plasmid cDNA clone, 45-A1, and N43- 
amp, two 60-mer oligonucleotides were generated based on the sequence 
of the 5' end of N43-amp (oligonucleotide  48) and the 3' end of 45-A1 (oligo- 
nucleotide 47) (see Fig. 4). These probes combined were used to screen 1.5 
million recombinants from an unamplified NISI eDNA library cloned into 
h Zap (Stratagene).  Phage lifts were performed as described (1). Prehybrid- 
ization, hybridization, and washing steps were identical to those used for the 
plasmid clones, pBluescript SK(-)-containing eDNA inserts were rescued 
from plaque-purified  clones as described by Stratagene.  Restriction analysis 
and sequencing was  performed on the  resulting plasmid.  These partial 
clones were again used to generate 60-mer oligonucleotides  based on ex- 
treme 3' and 5' ends (oligonucleotides  49 and 50). The screening of the X 
Zap library was repeated  as above.  Clones representing the remainder of 
the complete eDNA were isolated  and analyzed. 
DNA Sequencing 
DNA inserts from the pTZI8R-B  plasmids were subcloned into M13mpl9. 
Single-stranded phage was  recovered  from cells containing pBluescript 
plasmids as described by Stratagene.  Inserts were sequenced using synthetic 
oligonucleotide  primers (35) under conditions used by Tabor and Richard- 
son (36).  Sequencing  of double-stranded templates  was performed as de- 
scribed (30). 
Sequence Analysis 
Hydropathy  analysis (25),  secondary  structure predictions (4,  17), and 
amino acid sequence homology searches (27) were performed on an IBM 
Personal Computer using software obtained from DNASTAR,  Inc. (Madi- 
son, Wl). 
Endo H  Treatment of Nuclear Envelope Polypeptides 
Rat liver nuclear envelopes were salt washed with 500 mM KCI as described 
by Dwyer and Blobel (8). Salt-washed nuclear envelopes (,o125 #g of total 
protein) were digested with 0.05 U of Endo H (Boehringer Mannheim Bio- 
chemicals) in 200 mt of 0.1% SDS,  100 mM sodium citrate, pH 5.5, 3 mM 
DTT, 0.5  mM  PMSE  1130 kIU/ml  aprotinin,  and 0.25  /zg/ml  each  of 
chymostatin, antipain, pepstatin A, and leupeptin for 20 h at 37°C. A con- 
trol incubation did not contain Endo H. Both reaction mixtures were ana- 
lyzed by SDS-PAGE.  Polypeptides  were electrophoretically transferred to 
nitrocellulose (38), probed with 14C-labeled Con A (10), and then visual- 
ized by fluorography  as described (13). Alternatively,  blots were blocked 
with 3 % BSA in PBS and probed with a 1:200 dilution of rabbit anti-gp210 
(generated  against purified gp210)  in PBS containing 0.1% Triton X-100, 
0.02% SDS, and 1% BSA. Blots were washed four times with PBS contain- 
ing 0.1% Triton X-100 and 0.02% SDS and then reincubated  with a 1:1,000 
dilution of 1251-protein A  (Dupont Co.)  in PBS containing 0.1% Triton 
X-100, 0.02 % SDS, and 1% BSA. Blots were again washed and then exposed 
to x-ray film for autoradiography  at -80°C. Molecular weights were deter- 
mined using protein standards (Bio-Rad  Laboratories, Richmond, CA). 
Results 
Purification and Partial Protein Sequence  of  gp210 
gp210 was purified from rat liver nuclear envelopes using gel 
filtration and lentil lectin affinity chromatography.  Analysis 
of the purified protein by SDS-PAGE revealed a  single pro- 
tein band of ~  200 kD  (Fig.  1 a).  This purified protein was 
subjected to amino-terminal sequence analysis (Fig.  1 b). To 
obtain  internal  amino  acid  sequences,  gp210  was  cleaved 
with  cyanogen  bromide  or  S.  aureus  V8  protease.  After 
Figure  1.  Protein  sequence,  a 
shows a  Coomassie blue-stained 
SDS-PAGE profile of gp210 puri- 
fied from rat liver nuclei (see Ma- 
terials and Methods).  This frac- 
tion was used for amino-terminal 
and internal protein sequencing. 
b  summarizes  protein  sequence 
data  obtained  by automated  Ed- 
man degradation of uncleaved as 
well as S. aureus V8 protease and 
CNBr cleavage fragments of gp210 
as indicated (Origin). Individual 
peptides and their alignment with 
the deduced amino acid sequence 
(Fig. 5) are shown (Peptide). The 
sequences of the peptides are in- 
dicated (Sequence) with residues 
consistent with the cleavage spec- 
ificities  of CNBr  and S.  aureus 
V8 protease enclosed in brackets. Amino acids whose phenylthiohydantoin derivative HPLC peak areas were <50% of the analogous peak 
in the preceding cycle are underlined.  Dots above amino acids indicate a  deviation from the deduced amino acid sequence in Fig.  5. 
Wozniak et al. Primary Structure Analysis of a Nuclear Pore Protein  2085 Figure 2. Synthesis of the cDNA probe. Two 17-mer degenerate oligonucleotide primers were constructed according to amino acids  1-6 
(sense primer) and amino acids 31-36 (antisense primer) of the 40-amino acid peptide sequence p43-F4. Eco RI and Hind III linkers were 
incorporated at the 5' ends of the sense and antisense primers,  respectively (a). These primers were used with a cDNA template derived 
from size-fractionated RNA from N1S1 cells in an in vitro amplification reaction (see Materials and Methods). The products of this reaction 
were analyzed on 7% acrylamide gels and stained with 1/~g/ml ethidium bromide as shown in b, lane 2. Size markers (Msp I cut pBR322; 
New England Biolabs) are shown in lane 1. The major species running at '~123 bp was subeloned into pUCI9 and sequenced. The sequence 
of this product is shown in a along with the corresponding amplification primers and the translated amino acid sequence of the amplification 
product. 
separating  CNBr  fragments by SDS-PAGE,  several major 
bands  were excised and  electroeluted.  Alternatively,  frag- 
ments generated by V8 protease digestion were purified by 
reverse-phase HPLC. In both cases isolated fragments were 
subjected to automated Edman degradation.  Partial amino 
acid sequence of several fragments are shown in Fig.  1 b. 
revealed an open reading frame matching the amino acid se- 
quence of p43-F4 (Fig.  2  b). 
Northern Blot Analysis and Isolation of  cDNA Clones 
On  the  basis of the  sequence  of the  p43-F4  amplification 
Synthesis of the cDNA Probe 
A  single oligonucleotide probe was generated using varia- 
tions of a method described by Lee et al. (26). The procedure 
uses the polymerase chain reaction (31) in a mixed oligonu- 
cleotide  primed  amplification  of cDNA.  We  applied  this 
technique to a 40-amino acid stretch of overlapping peptide 
sequences from V8 protease fragment p43 and CNBr frag- 
ment F4 (termed p43-F4).  Two 17-mer partially degenerate 
oligonucleotide primers were designed based on amino acids 
1-6 (sense primer) and amino acids 31-36 (antisense primer) 
of p43-F4.  A  first-strand cDNA template was synthesized 
from poly A ÷ RNA isolated from the rat hepatoma cell line 
N1S1. Primers were then used in conjunction with the cDNA 
template in a  Taq polymerase-driven in vitro amplification 
reaction  (34).  The  predicted  product of this  reaction  is  a 
double-stranded DNA molecule of 123 bp with termini cor- 
responding to the 5' ends of the sense and antisense primers. 
As can be seen in Fig. 2 a the major product of the amplifica- 
tion reaction is ',,123 bp long. This band was isolated, sub- 
cloned into pUC19, and sequenced. Analysis of this sequence 
Figure 3. Northern  blot analysis. A 32p-la- 
beled  77-mer oligonucleotide  (termed 45) 
complementary  to the deduced mRNA se- 
quence of the p43-F4 amplification product 
was used to probe a Northern blot contain- 
ing 10/~g/lane poly A  + RNA of NISI cells. 
The final washing steps were performed in 
Ix SSC, 0.1% SDS at 60°C. The positions 
of RNA markers are indicated in kb. 
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Figure 4. Map of cDNA clones. Eight partial eDNA clones and two amplification products were chosen for bidirectional DNA sequence 
analysis. These are shown relative to their corresponding position in the mRNA. A schematic diagram Of the mRNA is shown calibrated 
in base pairs with the coding region boxed. The oligonucleotides used in the progressive isolation of eDNA clones are shown relative to 
their position along the mRNA. The first number used to designate the individual eDNA clones corresponds to the oligonucleotide used 
to isolate the clone. 
product,  a  single  77-mer oligonucleotide was  synthesized 
complementary to the deduced mRNA sequence. The 77- 
mer oligonucleotide was  used to probe Northern blots of 
poly  A+-selected  RNA  from N1S1 cells  and  identified a 
band of '~7 kb (Fig.  3). 
This probe was used to screen a plasmid cDNA library de- 
rived from size-selected poly A + RNA.  Three clones were 
identified of which one, 45-A1,  showed two regions corre- 
sponding to known peptide sequences. This enabled us to use 
the 5' and 3' ends of 45-A1  to construct two 60-mer oligo- 
nucleotides.  These oligonucleotides were  in turn  used  to 
screen an unamplified k Zap cDNA library. Sequence infor- 
mation from positive clones was  again used to synthesize 
flanking  oligonucleotides  with  which  the  screening  was 
repeated. 17 additional clones were isolated and partially se- 
quenced. Flanking oligonucleotides were again synthesized 
and the screening procedure was repeated again. In total, 40 
independent clones were isolated which spanned the com- 
plete cDNA of gp210.  Of these,  10 clones were completely 
sequenced on both strands.  The alignment of these clones 
and the positioning of the probes are shown in Fig. 4. In- 
cluded in this map are two amplification products, N43-amp 
and COOH-amp, which were subcloned and bidirectionally 
sequenced to confirm the cDNA sequences in regions where 
we did not have overlapping clones. Together, the eight par- 
tial clones and the two amplification products provide at least 
two independent sources of sequence data across the entire 
coding region of gp210. 
Nucleotide Sequence 
The overlapping clones establish a 6,964-bp contiguous se- 
quence (Fig.  5)  with  the  following features.  2 Near the 5' 
end, and ATG initiation codon at nucleotide +1  is flanked 
by an A at position -3 and a G at position +4 consistent with 
the most highly conserved bases found at eukaryotic transla- 
tional start sites (24). The length of the 5' untranslated leader 
was verified with primer extension analysis. This analysis in- 
2. These  sequence  data will appear  in the EMBL/GenBank/DDBJ  Nucleo- 
tide  Sequence  Databases  under  the  accession  number  Y00826. 
dicated multiple start sites for the initiation of transciption, 
giving rise to a 5' untranslated leader of between 15 and 35 
bases (data not shown). Within this range, the 5' most cDNA 
clone, 50-17, contains 30 bases of 5' untranslated leader. The 
initiation codon begins an open reading frame which extends 
for 5,658 bases to a TAG termination codon. The coding re- 
gion is followed by 1,230 bases of 3' untranslated DNA with 
a potential poly A addition site, AATAAA (33), at position 
6,885  and a poly A tail starting at position 6,913. 
Amino Acid Sequence 
Beginning with the initiator methionine, the eDNA codes for 
a polypeptide of 1,886 amino acids with a calculated molecu- 
lar mass of 204,205 D (without carbohydrate) (Fig. 5). Nine 
peptide sequences, totaling 177 amino acids, align with the 
sequence deduced from the eDNA. These peptide sequences 
are uniformly distributed along the sequence verifying the 
authenticity of the cDNA clones. 
The hydropathic character of the deduced amino acid se- 
quence of gp210 was examined as shown in Fig. 6. The mean 
hydropathy within a  19-amino acid window was calculated 
using the values of Kyte and Doolittle (25).  When plotted 
against the residue number, three peaks of hydrophobicity 
emerge with values >1.5. The first peak, with a value of 1.54, 
lies at the amino terminus. The 25 amino acids comprising 
this  hydrophobic domain agree well  with  the  established 
structural characteristics of a signal sequence (40). The se- 
quence Ala-Val-Ala at positions 23-25 is consistent with the 
(-3,-1) rule for signal peptidase cleavage sites (41). This is 
followed by amino acid 26, which begins a stretch of amino 
acids matching the amino-terminal protein sequence of  gp210. 
The two major peaks of hydrophobicity are seen near the 
carboxy terminus at positions 1,495 and 1,818. Their mean 
hydrophobicity values are 2.27 and 2.25, respectively. Based 
on these values, it is possible that these amino acid segments 
function as transmembrane domains (25). 
Between the amino terminus and the first predicted trans- 
membrane domain there are 13 potential sites (NXS/T) for 
N-linked oligosaccharide addition. The binding of gp210 to 
Con A  (19)  indicates that at least some of these sites are 
Wozniak  et al.  Primary Structure Analysis of a Nuclear Pore Protein  2087 -3Q  CCGCGCC~G~CGTAGcAAG~CC~GGAGG~G~GCGGGCCTCGCTGATACAGC~GGGGCTCTGGGCG~TGCTGTTGcTGCAGGCAGTG 
M  A  R  A  S  L  I  O  P  G  L  ~  A  L  L  L  L  (~  A  V  20 
6!  GGCCCCGCCGTGGCCGCCAAGCTTAACATT~C~AAGGTGCTGCTGC~CTTTA¢G~GAGC~ACG~GCGTGAACTTCACTCTGGAAGCTTCT 
G  P  A  V  A  |A  K  L  N  I  P  ](  V  L  L  P  F  T  R  A  T  R  V  N  F  T  L  E  A  S  50 
,  •  D  Amimo 
151  GAGGGCTGCTACCGCTG G  TCATCC  ACACGGCCAGAGGTAGCCAGCATAGAGCCATTGGGCTC  TAGTGAACAGCAGTnC TCCCAGAAGGCA 
E  G  C  ¥  R  W  5  $  T  R  P  E  V  A  $  I  E  P  L  G  S  S  E  Q  Q  C  S  O  K  A  90 
241  GTGGTGCAGGCCCGCCTGACCCAGCCAG~C~GCCTGAC~AGCAT~ATcTTTGCAGAAGACAT~A~TA~AGG~AGGTG~TG~GCTGCGAC 
V  V  0  A  R  L  T  O  P  A  R  L  T  S  I  l  F  A  E  D  I  T  T  G  0  V  L  R  C  D 
331  GCCATTGTTGATCTCATCCACGGCATTCAGATTGTCTCTACCACCCGTGAG•TCTATCTTGAGGACTCTC•G•TGGAGCTGAAGAT•CAG 
A  I  V  D  L  I  H  G  I  Q  I  V  S  T  T  R  E  L  Y  L  E  D  $  P  L  E  L  K  I  Q 
421  GCTCTGGACTC~GAAGGGAATA~CTTCAGTACCCTGGCAGGC~TGGT~TTTGACTGGA~AATTGTGA&GGATA~AGAGGCCAATGGATTC 




511  TCA•ACT•CCA•AATGCACTACGAATCCT•ACCTTCTTGGAATCTA•ATATATC•••••TT••TACAT•TCAGAGATGGAGAAGGCA••C 
SDSHNALRILTFLESTYIPPSYISE|MEKA~  200 
601  AAACAAGGCGACACCATCCTGGT~TCTGGGATGAAGACTGGAAGCTCCAAGCTCAAGGCTAGAATTCAGGAGG~TGT~TACAAGAATGTT 
KQGDTILVSGMgTGSSKLKARIQEAVyKN~  230 
691  CGCC~TG~G~AAGTCAGGCTGCTGA~CTTGGAGAACATCCTTCTGAATCCA~CCTATGATGTTTA~TACTGGTGGGGACGT~CATTCAC 
RPAEVRLLILENILLNPAYDVYLLVGTSIH  260 
Pp43-F4 
781  TACAAGGTTCAGAAGAT~AGG~AGGGCAAGATTACAGAACTCTCAATGC~TTCCGAT~AGTA~GAGCTGCAGCTC~AGAA~AGCATCCCA 
yKVQKIRQGKITELSMPSDQYE|LQLONSIPD  290 
871  GATCCC•A•GGAGACCCTGCCCGTCCTGTGGCCGTCCTGA•••AGGACACATCAAGAGTCACTG•CATG•AGATGGGA•AGAG••A•CTG 
DPQGDPARPVAVLTQDTSRVTAMQMGOSNL  320 
D p55 
961  GTCCTGGGCCACAGGAGCATC•GTATGCAAGGAGCTT•TAGG•TGCCCAA•AGCAC•ATCTATGTGGTTGAAGCCGGGTACCTAGGCTTC 
VLGHRSIRMOGASRLP~NTIYVVEAGYLGF  350 
1051  ACAGTTCACCCTGGTGACAGGTGGGTGCTTGAGACTGGACATCTGTATGCAGTTACCATCGAAGTATTTGATAGATCCAGCAACAAGGTC 
TVHPGDRWVLETGHLYAVTIEVFDRSSNKV  380 
1141  TACCCGTCTGACAACATC•GAATTGAAGCTGTGTTTCCTGCTGAGTTTTTTGAGGTTCTGTCATCTTCC•AGAATGGGTCTTATCATCAT 
¥PSDNIRIEAVFPAEFFEVLSSSQ~GSYHH  410 
1231  GTCAGGGCT•TCCAGAGTCGCCAGACGACCATCAGTGCAAGCCTCACCTCTGTGGTGGACCAGGATGGTGGAGTCC&TGTG•TTCAG•TA 
VRAIQSGQTTISASLTSVVDQDGGVHVLQV  940 
1321  CCTGTGTG•AACCAGCAAGAAGTAGACATTCATATACCCATCACACTCTATCCCAGCATCCTGACGTTTCCATGGCAA•CAAAGACAGGA 
PVWNQQEVDIHIPITLYPSILTFPWQPXTG  470 
1411  GCCTATCAAT~TACTATAAAGG~C~ATGGGGGCAGTGGGAACTTCA~CTGGTCTTCCT~GA~CTACATGGTTGCCA~GGTTACTGTCAAG 
AYQYTIKAHGGSG~FTWSSSSYMVATVTVK  500 
1501  GGTGTCATGAC•ACAGGCGGTGACACTGG•CTCAGTGTGATCCGGGCACATGATGTTCAGAACCCTCTCCATTTTGGTGAGATGAAG•TG 
GVMTTGGDTGLSVIRAHDVQNPLHFGEMKV  530 
1591  TATGTGATTGAGCCCA•CAGCATGGAGTTTGCCCCGTGCCAGGTGGAGGCTCGAGTGGGTCACACCCTGGAGCTG•CCCTGACAATCAGT 
YVIEPSSMEFAPCQVEARVGHTLELPLTI$  560 
1681  GGCCTCATGCCCGGTGGGAGCAGCGAGGTGGTCA•CCTGAGCGACTGCTCC•ATTTTGACCTG•TG•TG•AGGT•GAGAACCAGGGTGTG 
GLMPGGSSEVVTLSDCSHFDLVVEIVENQG  ~,  590 
1771  TTCCAGCCATTGCCAGGGAG~CTGCCACCAG~GCCTGAGCACTGCAGTGGAGTCAAA~TGAGAGCTGAT~CCCAGGGGTCCACTACCCTC 
FQPLPGRLPPGPEHCSGVKVRADAQGSTTL  620 
'  p30 
1861  CTTGTCAGCTA•ACACATGGCCATGTGCACTTGGGTGCAAAGATCACTCTTGCTGCCTACCTGCCCCTCAAGGCTGTGGATCCCTCTTCT 
LVSYTHGHVHLGAKITLAAYLPLKAVDPSS  650 
1951  GTTGCTGTGGTAACCCTGGGATCCTCAAAGGAGATGCTGTTTGAAGGAGGCCCCAGGCCATGGGTCCTGGAACCTTCCAAATTCTTTCGG 
VAVVTLGSSKEMLFEGGPRFWVLEPSKFFR  680 
2041  AATGTCACTTCTGAAGACACAGGCAGCATCAGTCTCTCT~TCTTGGGT~CTC~AGC~TCTCGGAATTACCAGCAGCACCGGGTCCTTGTG 
~  VTSEDTGSISLSLLGPPASRNYQQHRVLV  710 
2131  AC•TGCCAGGCCCTGGGTGAGCAGGTCATCGCCCTGTCTGTGGGGAACCGGCCCAGCCTCTCTAACCCCTTCCCTGCTGTGGAGCC•ACT 
TCQALGEQVIALSVGNRPSLSNPFPAVEPT  740 
2221  GTGGTGAAATCCGTCTGCGCCCCACCGTCCAGGCTTACTCTCATGCCTGTCTATGCCCTCCCGCAGCTCGACCTCTCTTGTCCATTGCTG 
VVKSVCAPPSRLTLMPVYALPQLDLSCPLL  770 
2311  CAG•AGAATAAGCAGGTGGTTCCAGTATCCAGTCACCGCAAT•CCCTGTTAGACCTGGGTGCTTATGACCAA•AAGGCCGG•GATTCGAT 
QQNKQVVPVSSHRNPLLDLGAYDQQGRRFD  BOO 
2401  AACTTCAGCTCTCTGAGCATC•AGTG•GA•TCCTTTCGGCCACTGCTGGCCAGCATTGAGGTTGACCAGCCCATG•AGCTGGTATCC•AG 
~  FSSLSIQWESFRPLLASIEVDQPMQLVSQ  830 
2491  GATGATGGGAATGG•CAAAAGAAACTACATGGTTTGCAGAC•GTTTCGGTTCACGAGGCATCAGGAACCACAGC•ATCTCTGCCACGGCG 
DDGNGQKKLHGLQTVSVHE|ASGTTAISATA  860  | 
2581  ACTGGCTACCAGCAGTC~ACCTGAGTGCAGCCGGAGTGAAGCAGCTG~GTGACCCTCTAGTACCTGTGTCAGCCTCCATTGAGCTTATA 
TGYQQSHLSAAGVKQLRDPLVPVSASIELI  890 
'  p59 
2671  CTCGTAGAGGATGTGAGGGTCAGTCCAGAAGAAGTGACCATCTATAACCATCCTGGTGTCCAGGTAGAACTCCACATCACAGAAGGCTCT 
LVEDVRVSPEEVTIYNHPGVQVELHITEGS  920 
2761  GGCTATTT~TTCCTCAACACAAGCA~CCAGGACATCATCAATGTGGCCTAC~AGGACACCCGGGGCGTGGCTATGGTG~AT~CTCTGTTC 
GYFFL~TSTQDIINVAYQDT~GVAMVHPLF  950 
2851  ~CAGGCTCATCAACTGTCATGGTCCATGACTTGTGCCTGACCTTCCCAGCCCCAGCAAAGGCCACCATTCAT~TCTCCGA~ATCCAGGAG 
PGSSTVMVHDLCLTFPAPAKATIHVSDIQE  980 
2941  CTCTATGTCCGAGTGGTGGACAAGGTGGAGATCGGGAAGGCTGTCAAGG~CTATGTCCGTGTGTTGGACTTCTACAAGAAGCCTTTCCTG 
LYVRVVDKVEICKAVKAYVRVLDFYKKPFLI010 
3031  GCCAAGTACTTCACCTTTATGGACCT•AAGCTG•GAGCAGCCTCCCAGATCATCA•G•TGGTGACTCTGGATGAAGCT•TAGACAATTA• 
AKYFTFMDLKLRAASQIITLVTLDEALD~yI040 
The Journal of Cell Biology,  Volume  108,  1989  2088 3121  ACGGCCACATTCCT TGTGCACGGCGTGGCCATTGGCCAAACCAGCCTGTCGGCAAGTGTGACGGACAAATCTGGGCAG&GAGTCAGCTCC 
T  A  T  F  L  V  H  G  V  A  I  G  Q  T  5  L  S  A  S  V  T  D  K  S  G  Q  R  V  S  S  1070 
3211  ACCGCACAACAGATCGAGGTCT  TCCCCCCATTCAGACTGATACCAAGGAAGGTGACACTGATTATTGGAGCCATGATACAGATCACCTCC 
T  A  Q  Q  I  E  V  F  P  P  F  R  L  i  P  R  K  V  T  L  I  I  G  A  M  I  0  I  T  S  1100 
3301  GAGGGCGG~CCCCAGCCTCAGTCCAACATCCTCTT~T~ATCAA~AATGAGAGTGTGG~TGcAGTGAG~AGcGccGGG~TGGTGcGTGGG 
E  G  G  P  O  P  Q  S  N  I  L  F  S  I  N  ~  £  $  V  A  A  V  S  S  A  G  L  V  R  G  1130 
3391  CT CATGGTTGGCAATGGCTCTGTACTGGGAGTTGTGCAGGCAGTGGATGCCGAGACTGGCAAGGTCATCATCGTC  TCCCAGGATCATG  TG 
L  M  V  G  N  G  5  V  L  G  V  V  Q  A  V  D  A  E  T  G  K  V  I  I  V  S  0  D  B  V  1160 
3461  GAAG  TAGAGG  TGC  TACAGC  T  CCAGGCAG  TGAGGATCCGAGCCCCGATCACACGAATGAGGACCGGGACCCAGATGCCTGTCTATGTCACC 
E  V  E  ,V  L  Q  L  O  A  V  R  I  R  A  P  I  T  R  M  ,R  T  G  T  0  M  P  V  ¥  V  T  1190 
I  p74  ~  ~  F3 
3571  GGGAT~AC~AG~AACCAGAGCC~TTT~TC~TTTGG~AATG~TGTG~AGG~TGA~TT~A~TGGT~TGT~A~AAGAGGGATGT~CTG 
G  I  T  S  ~  (~  S  P  F  5  F  G  g  A  V  P  G  L  T  F  R  w  S  V  T  K  R  D  V  b  1220 
3661  GACCTTCGAGGACGGCA••ATGAGGTGTcAATCCGGCTcTCG••T•AGTACAATTTTGC•ATGAATGTGC•TGG••GGGTGAAAGGTCGG 
D  L  R  G  R  B  H  E  v  s  1  R  L  s  P  Q  ¥  N  F  &  M  ~  v  H  G  R  v  ~  G  R  1250 
3751  ACTGGACTGCGG•TGGTGGTCAAAG•TCTGGAC••CA•AG•TGGG••GCTG••TGGT•T•GG•AAGGAGcT•T•AGATG•GATCCAAATT 
T  G  L  R  V  V  V  K  A  L  D  P  T  A  G  0  L  H  G  L  G  K  E  L  $  D  E  I  Q  I  1280 
3841  CAGGTATT  TGAAAAACTGCGGC TGCTGAACCCTGAAGTAGAAGCAGAACAAATACTAATGTCACCTAACTCGTTTATAAAGCTGCAGACA 
O  V  F  E  K  L  R  L  L  N  P  E  V  E  jA  E  0  I  L  M  S  P  N  S  F  I  K  L  Q  T  1310 
l  o 
3931  AACAGGGATGGTG•AGCCATTCTGAG•TACCGGGT•CTCGATGGGCCTGAGAAGGcT•••ATCGTG•A•ATTGA•GAGAAGGGCTTTCTG 
N  R  D  G  A  A  I  L  S  Y  R  V  L  D  G  P  E  K  A  P  I  V  H  I  D  E  K  G  F  L  1340 
L p63 
4021  GTGTCCGGCTCTGGGATTGGAGTGTCCACC•TCGAAGTGATTGCACAGGAG••TTTCGGCA•CAAC•AGA•TGT••TTGTCG•TGTAAAG 
V  S  G  8  G  I  G  V  5  T  L  E  V  I  A  Q  E  P  F  G  T  ~  0  T  V  L  V  A  V  K  1370 
4 I  1  i  GT~TCTCCTATTTCATACCTGAGGATCT~ATGAGC~CAGTC~TG~ACACTcAG~A~A~GGAGGTG~TGACAG~TCTG~rT~TGGGGATG 
V  S  P  I  S  Y  L  R  1  S  M  S  P  V  L  H  T  O  H  K  E  V  L  T  A  L  P  L  G  M  1400 
4201  ACTGTGACCTTCACTGTCCACTTCCATGACAGCTCTGGAGACATCTTCCACGCTCATAATTCAGA•CTCAATTTCGCTAcTAACAGAG•T 
TVTFTVRF~DSSGDIFHAHNSDLNFATNRD1430 
4291  GACTTCGTGCAGATTGGCAA•GGGGC•ACCAACAACACCTGCATCATCCGcACAGTCAGTGTGGGCTTGACA•TGCTcCACGTGTGGGAT 
DFVQIGKGAT~NTCIIRTVSVGLTLLHVWD1660 
4381  GTGGAACATCTCGGCCTCT•CGACTTCGTGC•ACTACCTGT•CTG•AGG•CAT•A••••AGAGTTGT•TGGAG•TGTGGTGGTGGG•GA• 
VERLGLSDFVPLPVLQAITPE[LSGAVVVGD1490 
4q71  ATCCTCTGCCTG•CTAG•GTTCTCATTA••CTGGGAGGTGT•T•AGGGACCTGGAGCTC•TCAG•TGGCAATGTcCT•TATGTTGACCC• 
ILCLASVLISLGGV]SGTWSSSAGNVLYVDP1520 
4561  AAGACAGG•GTGGCTATAGC•CGA•ATGCAGGGC•TGTGACTGTTTACTATGAAATCG•TGGAcATCTGAAGACCTTCAAGGAGATAGT• 
KTGVAIARDAGPVTVYYEIAGHLKTFKEIVI550 
4651  GTCGTCACCC•TCA•AA•ATTGTGG••••TCG•CTCCACG••A•G•AGAC•A•TAT•CAGGAAG•CA•AG•CTcTAAAGTGA•TGT•AGC 
VVTPQKIVARRLHATQTSIQEATASNVTVSI580 
4741  GTGGGAGACAGGAGCTCT~ACCTACTTGGTGAGTG~TCCTCTGCCCAGCGAG~GG~ATAGAAG~TTGCA~KGAGT~C~TCAT~G~ 
VGDRSSNLLGECSSAQREAIEALHPESLISI610 
4831  TGCCAA•T•CAGTTCAAGCAAGATGTCTTTGACTTCC•TGCTCGTGACATCTTCT•TGTGGAACCAGGATTTGATA•TGCA•TGGGCCAG 
C~LQFKQDVFDFPARDIFSVEPGFDTALGQI640 
4921  TA••TCTGCTCGGTTA•TATGCACAGA•TGA•AGATAAG•AA•TGAAGCACTTGAACATGAAGAAGA•ATCAcTGGCGGT•A••GCCT•• 
¥LCSVTMERLTDKQLKHLNMIKKTSLAVTA516~O 
'~  F7 
5011  ATG•CTAGCAGCCGTA•ATCTGTAGAAAAGGTGGGAGCTGAGGT•CCCTTCAGTC•AGGGCTCTATG•CAAC•AGGcAGAAATCCTTTTG 
MPSSRTSVEKVGAEVPFSPGLYANOAEILLITO0 
5101  AGCAA~CACTACCC~AGCTCCGAGGT~AAGATCTTCGGTG~TGTGGAAATTCTGGAAAACTTGGAGGTGAGGTCCGGGT~CCCAG~AGTG 
SNHYPSSEVKIFGAVEILENLEVRSGSPAVI730 
5191  CTAGCCTCCGTGAAAGAGAAGTCATTTGGACTGCCCAGCTTCATCA•GTACACAGTTGGTGTCTTGGAT•••ACAGCTGGCAGCCAAGGC 
LASVKEKSFGLPSFITYTVGVLDPTAGSQG1760 
5281  CCTCTGTCCA•TGC•CTGACCTTCT••AGTCCTGCCACTAACCAGGC•ATCA•CATTCCAGTCACTG•GGC•TTTG•GTTGGAT•GT•GT 
PLSTALTFSSPATNOAITIPVTVAFVLDRR1790 
5371  •GGCCTGGTCCCTATGGAGCCAGC•T•CTGTCACACTT••TGGACT••TATCAAGTCATGTT•TTCA•CTTT•TTGc•CTGCTGGCTGGG 
GPGPYGASLLSHFLDSYQ~VM?FTFFALLAGI820 
5461  ACAGCAGTCACCATTATAGCCTAC•ACA•GGTCTGTG•A•CCCGGGAA•TTG•TTCA••ACTGGC•CTCA•GCC••ATGCCAG•CCT•AG 
TAVTIIAYJHTVCAPRELASPLALTPHASPQI850 
5553  CACAGCCCCCACTATCTTG•CTCATCCCCGACTGC•TT•AACACACTGCC•TCTGATCGCAAAGCCAGCC•TCCCT•AGGG•T•TGGAGC 
ESPHYLASSPTAFNTLPSDRKASppSGLW3188C 
5641  CCAGCCTATGCCTCTCAC~GCAGTGTG~AGGGCTGGTATTGCTACACAGCTGAACTGA~AC~TGGA~AAAAGGGT~A~TGTCGTTTTC 
P  A  Y  A  5  H  1886 
5731  ACACGGTAAAA••ACG•CTGGGC•CTAGGCCAT•CTCA•TG•CCTGGCTGTGCTGAACCACTGCCTGATT•ACACAAGCAAGGGTTTTTA 
5821  ATTTGTTTG•TTTTAATT•T•TTTC•AAGC•TTGAGGGCCAGGGCTTC•TGGTTC••T•TTTCT•ATGTGG¢GTG•AGGATATGGGGGTG 
5911  CTGCTTGATGTTGTTTTTGTAAT~TC~AGAAAGCT~Ac~TCTGTT~ATGGCTTTAAGTG~TGGAAG~TGTCTACAT~ATCTA~AGAT 
6001  GATGCCATCATAG•GAT•TcAGGGAAAGGATGT••T•ATCA•T•CTGGGGATTT•GTGGTGCTTGGAATAGAA•CCAGGGTCTCA•G••T 
6091  G•TTGC•AATTGTTTGTC•A•TGGCA•GTGCA•ACA•CAGcC•TTTTTTGTTTTGTTTTGTTTTGTTTT•ATGAATACTTGT••TG•TGC 
6181  TACTAGGAAATGTGGAGGACAAG~AGGTGTGG~TGT~C~TAGGGGA~cTG~C~AGA~C~cTGTG~TGT~TGAG~TTA~TGTG~TTGT 
6271  TACTGAGCCTCAG••GAGTAG•T•TC••GTTTTGG•AGAAGGGCTTcTGTCA•TGGTG•TG•AGTG••TCT•G•TCT•C•TGACG•AGCT 
6361  TGGGAAGAG•AGAG•ATTGTTGGc••TGc••TGAAG•CA•TGGNGGGGATcTTCTAAT•T•TGG•TTTGTT•TGAGATG•TG•TATGAGT 
6451  TGTGGAG~CGAGAGA~CA~TGTGGT~TCTTCTT~TGCC~TGGAAGA~CCCGAACACAGTA~TTGGTGGATGTGAA~cA~TATT~G~ 
6541  c~T~TCTCCT~T~CTCTGc~A~CAG~GCTCTcCTAG~TG~CC~GGAAC~G~AGAGGATTc~TTGAGTCTACAA~TTcA~AT~TGAAC 
6631  TCAGGGACATGGC•A•T•TG•TT•&GGTT•AGGTG•TGTGG•••TGT•GGAGC•AGA••CTCAcGAGTGGA•GTGTATGGG•Ac•A•AT• 
6721  AGT•ACcAAGAGTT•AG••AG••TTTGAAGGT•TTATGTGGTT••TTGTAT••TTTGAGA•TGAG••A•AAGATGGACTTTT•TGGAG•T 
6811  GGGGA~AGAGG&TTTGTGT~AG~TGT~GcTTAAT~TcTccc~GGAGTTATGGAGT~TGcccTGcA~TTGTT~-~-A~TT~TGTGT& 
6901  GTTTCTTAAAGGAAAAAAAAAAAAAAAAAAAAAA  6934 
Figure 5. Complete cDNA and deduced amino acid sequence ofgp210. Nucleotides are numbered on the left with the +1 coordinate assigned 
to the first nucleotide of the reading frame.  Amino acids, represented by their one-letter code, are numbered on the right.  The initiation 
codon, the termination codon, and the poly A  addition site are boxed. Positions corresponding to the peptide sequence information in 
Fig. 1 are underlined by arrows. The signal sequence is indicated by a heavy bar and the two predicted transmembrane domains are boxed. 
Potential  sites for asparagine-linked  oligosaccharide addition are indicated  by solid boxes. 
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Figure 6.  Hydropathy profile of 
gp210. Hydropathic values of in- 
dividual amino acids were aver- 
aged within a 19-amino acid slid- 
ing window as described by Kyte 
and Doolittle (25). Mean values 
were assigned  to the middle amino 
acid residue and plotted against 
the residue number. Peaks of hy- 
drophobicity corresponding  to the 
signal sequence (SS) and the two 
predicted transmembrane domains 
(TM/and TM2) are indicated. 
glycosylated. We show in Fig. 7 b, lane 2, that Con A binding 
to gp210 can be nearly abolished by treating SDS-solubilized 
nuclear envelopes with Endo H. Immunoblots of these frac- 
tions suggest Endo H-sensitive carbohydrates contribute '~9 
kD to the mass of gp210 (Fig. 7 b, lanes 3 and 4), implying 
that only a fraction of the available N-linked glycosylation 
sites are used. These results are similar to those obtained for 
the Drosophila homolog (2a). 
An examination of the deduced amino acid composition of 
the total protein reveals no unusual features (6).  However, 
the region on the carboxy-terminal side of the second puta- 
tive transmembrane domain, containing the carboxy-terminal 
58 amino acids,  is relatively rich in serine, alanine, and, 
more strikingly, proline and histidine. Within this domain, 
a structural motif of P X~ P X6 P X6 P X~ P lies just before 
the carboxy terminus. Interestingly, this 58-amino acid do- 
main also contains an H  X2 C  X~8 H  X2 H motif. This is 
similar to a  general sequence motif found in a  variety of 
metal ion-binding proteins (2).  However, to date no such 
function has been described for gp210. 
We have used the methods Garnier et al. (17) and Chou and 
Fasman (4) to predict the overall secondary structural char- 
acteristics  of the  deduced amino  acid  sequence.  Neither 
method reveals a prevalence of o~-helical or extended B-sheet 
conformations. Additionally, dot-matrix searches reveal no 
evidence of internally repeated sequences of significant length. 
Finally, searches  against currently available  protein  data 
bases reveal no significant homology. 
Discussion 
We present here the primary structure for a previously iden- 
tiffed integral membrane protein of the nuclear pore (termed 
gp210). The primary structure consists of 1,886 amino acids 
with a predicted polypeptide mass of 204,205 D. The sub- 
traction of,',,3 kD for signal sequence removal and the addi- 
tion of '~9 kD of carbohydrate raises the predicted mass to 
210 kD. This value is 10-20 kD larger than that estimated 
by SDS-PAGE. 
Beginning with the amino terminus of mature gp210  we 
have arbitrarily divided the amino acid sequence into three 
seqments (A, B, and C) separated by two predicted trans- 
membrane segments (TM1  and TM2) as shown in Fig. 8. 
Starting at the signal peptide cleavage site at amino acid 26 
and continuing for 1,481 amino acids, an '~161-kD segment 
(segment A) precedes the first predicted transmembrane seg- 
ment. Contained within this region are all 13 potential accep- 
tor sites (NXS/T) for N-linked oligosaccharides. It has been 
shown previously that gp210  contains high mannose-type 
oligosaccharides based on its ability to bind Con A (19). We 
have shown independently, using Endo H  treatment,  that 
these  carbohydrate moieties represent  ,~9kD  of the total 
mass of gp210. These data imply that only a fraction of the 
potential N-linked oligosaccharide addition sites are actually 
used. Segment A, with "o9 kD of oligosaccharide attached, 
would contribute ,'~170 kD of mass to gp210.  This is sup- 
ported by protease experiments in which mild trypsinization 
releases a Con A-binding domain of gp210 from unsealed rat 
liver nuclear envelopes of an estimated mass of 180 kD (data 
not shown). Similar results have been obtained with papain 
digests of nuclear envelopes (Gerace, L., personal commu- 
nication).  In  both  cases,  the  protease  would presumably 
cleave the molecule near the first putative transmembrane 
segment during the initial stages of digestion. 
At the carboxy-terminal end of segment A  lies the first 
predicted transmembrane segment.  This  is  followed by a 
304-amino acid (33 kD) region, segment B, which leads to 
the second predicted transmembrane segment. This second 
transmembrane segment precedes a 58-amino acid carboxy- 
terminal tail (segment C). The deduced amino acid composi- 
tion of segment A and B are quite similar. Segment C, how- 
ever, is relatively rich in alanine, serine, histidine, and pro- 
line. Most striking is the number of prolines including a P 
X6 P X6 P X6 P X6 P motif near the carboxy terminus. The 
abundance of prolines is likely to impart a degree of rigidity 
and, on the basis of secondary structure analysis (4,  17), 
numerous turn~ on this segment. A comparison of  this region 
to available data bases reveals no significant similarities that 
might provide clues to its function. 
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of the nuclear membrane and segment C  extends back into 
the perinuclear space. With these models in mind, it is in- 
teresting to note that TM1 is contained within the latter half 
of a relatively hydrophobic stretch of 41 amino acid residues 
(1,469-1,509).  Hydropathy analysis reveals two overlapping 
hydrophobic peaks within this region (Fig. 6). In this stretch 
there are only two charged residues. This differs from the en- 
vironment surrounding TM2 which is more tightly bordered 
by charged amino acid residues,  a  characteristic often as- 
sociated  with  transmembrane  segments  (5).  The  adjacent 
positioning  of  the  two  hydrophobic  segments  within  41 
residues may provide a basis for the cooperative interactions 
of both segments with the lipid bilayer (9). Such an interac- 
tion could potentially serve to significantly disrupt the mem- 
brane and, if  juxtaposed to an adjacent membrane, act to ini- 
tiate membrane fusion. A fusion event would be required for 
pore formation (see below). 
It has previously been proposed that gp210 might be in- 
volved in anchoring the pore complex to the nuclear mem- 
brane (19).  The presence of predicted transmembrane seg- 
ments in the primary structure further supports this idea by 
positioning a portion of gp210 on the pore side of the nuclear 
membrane.  If involved  in  an  anchoring  function,  gp210 
would be positioned to either directly or indirectly influence 
Figure 7. Endo H digestion of nuclear envelopes. Salt-washed nu- 
clear envelopes incubated with (+) or without  (-) Endo H were 
analyzed  on 8%  SDS-polyacrylamide gels.  The resulting profile 
was examined directly by Coomassie blue staining (a) or transferred 
to nitrocellulose and probed with 14C-Con A (b, lanes 1 and 2) or 
rabbit anti-gp210 (b, lanes 3 and 4) as described  in Materials and 
Methods.  Con A binding to gp210 is nearly abolished in the Endo 
H-treated sample (b, lane 2). Antibody binding reveals an '~9-kD 
decrease in the apparent mass of gp210 after Endo H digestion (b, 
lane 3). Molecular mass markers are shown in a, lane 1, with their 
mass indicated in kD. 
Outer Nuclear  Membrane 
I 
.... 3~___.__~ 
I  Perinuclear  ~  Pore 
Space 
I 
Inner  Nuclear  Membrane 
II 
Previous data  suggested that gp210  is an integral  mem- 
brane protein  (19),  implying that  it  contains  at  least one 
transmembrane segment.  Our primary structural data sug- 
gest that gp210 contains two transmembrane segments. We 
propose three possible models for the topology of gp210 in 
the nuclear membrane. The models use either the first (mod- 
el I), the  second (model II), or both (model III) predicted 
transmembrane segments. All three models place the large 
glycosylated segment A within the perinuclear space. Model 
I shows gp210 anchored to the nuclear membrane via the first 
transmembrane segment with  segment B,  the  second pre- 
dicted transmembrane segment, and segment C on the pore 
side of the nuclear membrane. Model II anchors gp210 to the 
membrane using only the second predicted transmembrane 
segment and, thus, places segment B on the cisternal side of 
the membrane. In this model only the 58-amino acid-long 
segment C  would extend towards the pore.  Model III sug- 
gests that both predicted transmembrane segments are used, 
Figure 8.  Models for the topology of gp210 in the nuclear mem- 
brane. Three possible models for the topology of gp210 using the 
first (model I), the second (model II), or both (model III) predicted 
transmembrane  segments  (TM1 and TM2)  are shown schemati- 
cally. In all models gp210 is positioned at the nuclear pore;  i.e., 
at the junction  between the inner and outer  nuclear membranes. 
The segments of gp210 as described in the text are indicated as fol- 
lows. (m) Segment A; (B) segment B; (FJ) segment C. Glycosyla- 
tion of segment A is schematically shown by arrowheads. Based on 
the twofold symmetry in the plane of the envelope and the perpen- 
dicular  eighffold  symmetry  of the  nuclear  pore complex,, there 
could be 16 molecules of gp210 per nuclear pore.  For this reason 
we have drawn two molecules per model. 
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identical to those found in the nuclear envelope are also ob- 
served in annulate lamellae, gp210 would be expected to per- 
form a similar function within these organelles. 
The primary structure of gp210 raises certain questions 
about the biosynthesis and subsequent integration of this pro- 
tein into the ER membrane. The first 25 amino acids of the 
primary sequence conforms with the established ER-targeted 
signal sequence motif (40).  An amino-terminal protein se- 
quence obtained from the mature protein begins  at amino 
acid 26, implying the signal sequence has been removed. The 
presence of a cleavable signal sequence  would presumably 
initiate the translocation of segment A into the lumen of the 
ER. This translocation would continue until stopped by ei- 
ther the first (model I) or second (model II) transmembrane 
segment. For the topology shown in model III, a second sig- 
nal sequence located in the second transmembrane segment 
might accomplish  translocation of segment C. 
After integration into the ER membrane, gp210 might be 
recruited into an octameric patch (see introduction) by lateral 
diffusion  in the plane  of the membrane.  Patch formation 
could  potentially be triggered by association  with compo- 
nents of the pore complex. Two such patches in the ER mem- 
brane or the nuclear envelope,  where superimposed within 
adjacent bilayers, may lead to focalized  membrane fusion 
giving rise to transcisternal pores in either annulate lamellae 
or the nuclear envelope. Thus, gp210 may play a fundamen- 
tal role not only in the anchorage of the pore complex  but 
also in the formation of pores in the nuclear envelope and 
annulate lamellae. 
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